Concepedia

Derek Lowe

DL

18

Publications

1.6K

Citations

14

H-Index

1999

Active since

Affiliations

Bayer (United States)(Current)

Vertex Pharmaceuticals (United States)

Bayer (Germany)

Derek Lowe is an author at Bayer (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1999–2018

18

Publications

18

The promise and peril of chemical probes

C.H. Arrowsmith, James E. Audia, Christopher P. Austin et al. · Nature Chemical Biology · 2015 · 836 citations · Full text

Quinazolinone Derivatives as Orally Available Ghrelin Receptor Antagonists for the Treatment of Diabetes and Obesity

Joachim Rudolph, William P. Esler, Stephen O’Connor et al. · Journal of Medicinal Chemistry · 2007 · 157 citations · Full text

, , +17

LINGO-1, a Transmembrane Signaling Protein, Inhibits Oligodendrocyte Differentiation and Myelination through Intercellular Self-interactions

Scott Jepson, Bryan W. Vought, Christian H. Gross et al. · Journal of Biological Chemistry · 2012 · 103 citations · Full text

Specific Inhibition of Hormone-Sensitive Lipase Improves Lipid Profile while Reducing Plasma Glucose

Thomas H. Claus, Derek Lowe, Yin Liang et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 87 citations

SCH 57790, a selective muscarinic M2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals

Galen Carey, William Billard, Herbert Binch et al. · European Journal of Pharmacology · 2001 · 76 citations

, , +8

Rows per page

1–5 of 18